B+
Bull case
25%
Probability
Target price
$1.15
Analysis reference price unavailable
Analysis 2026-08-06 · RankAlpha Sentiment Codex
IVVD
InvivydCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
The positive case rests on an on-track pivotal VYD2311 program, Q3 2026 topline data, the planned LIBERTY follow-on study, continued PEMGARDA revenue growth, and cash support for trial and launch preparation.
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
Analyst target revisions, consensus estimates, options data, short interest, and social sentiment are unavailable.
Momentum
31
Value
41
Sentiment
68
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.68 · Bull $1.15 · Bear $0.30Analysis 2026-08-06; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-06 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $10.00
Why
Momentum31 · Δ7d -
Value41 · Δ7d -0.1
Sentiment68 · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Sentiment remains the lead driver in the composite.
Contradictions & invalidation
- • Analyst target revisions, consensus estimates, options data, short interest, and social sentiment are unavailable.
- • DECLARATION topline results could disappoint, be delayed, or fail to support approval.
- • The downside case is dominated by binary clinical efficacy and timing risk, uncertain future COVID demand, elevated clinical spending, and the Nasdaq bid-price deficiency.
Catalyst clock
2026-08-31
PEMGARDA revenue and balance-sheet support
Lead driver: Sentiment · See AI snapshot
Momentum
31
8% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
47% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.4
Sentiment
68
45% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 30.9 / Value 40.6 / Sentiment 67.5
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-06. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$0.68
Analysis reference price unavailable
Analysis 2026-08-06 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$0.30
Analysis reference price unavailable
Analysis 2026-08-06 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$180.81M
Beta
0.62
Shares Out
294.76M
P/E (TTM) · Derived
-2.0
P/S (TTM)
14.12
P/FCF (TTM) · Derived
-1.63
Rev YoY
+21.2%
EPS YoY
+13.3%
Gross Margin
+88.8%
Op Margin
-192.8%
Net Debt
-$224.2M
Current Ratio
5.87
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data